New hope for kids with kidney disease: fewer relapses with ripertamab?
Disease control
Not yet recruiting
This study looks at whether one or two doses of ripertamab can help children aged 16 and older who have frequent relapses or steroid-dependent nephrotic syndrome. The goal is to see if the drug can reduce relapses and the need for steroids over a year. About 312 children will tak…
Phase: NA • Sponsor: Mao Jianhua • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC